89 related articles for article (PubMed ID: 8809866)
1. Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injury.
Faden AI
NIDA Res Monogr; 1996; 163():318-30. PubMed ID: 8809866
[TBL] [Abstract][Full Text] [Related]
2. Opioids modulate post-ischemic progression in a rat model of stroke.
Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ
Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioids: therapeutic considerations in epilepsy and CNS injury.
Tortella FC; DeCoster MA
Clin Neuropharmacol; 1994 Oct; 17(5):403-16. PubMed ID: 9316689
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of hibernation-regulating substances against low-temperature-induced cell death in cultured hamster hippocampal neurons.
Tamura Y; Monden M; Shintani M; Kawai A; Shiomi H
Brain Res; 2006 Sep; 1108(1):107-16. PubMed ID: 16854391
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
6. Effect of mu and kappa opioids on injury-induced microglial accumulation in leech CNS: involvement of the nitric oxide pathway.
Yahyavi-Firouz-Abadi N; Tahsili-Fahadan P; Ostad SN
Neuroscience; 2007 Feb; 144(3):1075-86. PubMed ID: 17169497
[TBL] [Abstract][Full Text] [Related]
7. [Effect of neurotoxin on spinal cord injury in rats].
Ye X; Li M; Li J
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):31-4. PubMed ID: 11715537
[TBL] [Abstract][Full Text] [Related]
8. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors.
Hruby VJ; Agnes RS
Biopolymers; 1999; 51(6):391-410. PubMed ID: 10797229
[TBL] [Abstract][Full Text] [Related]
9. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
10. Peripherally-acting opioids.
Smith HS
Pain Physician; 2008 Mar; 11(2 Suppl):S121-32. PubMed ID: 18443636
[TBL] [Abstract][Full Text] [Related]
11. Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats.
Zhao P; Huang Y; Zuo Z
J Neuropathol Exp Neurol; 2006 Oct; 65(10):945-52. PubMed ID: 17021399
[TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenous opioid peptides in the antinociception induced by the novel dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Watanabe H; Moriyama K; Sato B; Ohwada K; Yonezawa A; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Apr; 560(2-3):150-9. PubMed ID: 17307162
[TBL] [Abstract][Full Text] [Related]
13. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage.
Liu B; Qin L; Yang SN; Wilson BC; Liu Y; Hong JS
J Pharmacol Exp Ther; 2001 Sep; 298(3):1133-41. PubMed ID: 11504811
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
Hauser KF; Knapp PE; Turbek CS
Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
[TBL] [Abstract][Full Text] [Related]
15. Comparison of opioid receptor distributions in the rat central nervous system.
Gray AC; Coupar IM; White PJ
Life Sci; 2006 Jul; 79(7):674-85. PubMed ID: 16546223
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
[TBL] [Abstract][Full Text] [Related]
17. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.
Zhang S; Tong Y; Tian M; Dehaven RN; Cortesburgos L; Mansson E; Simonin F; Kieffer B; Yu L
J Pharmacol Exp Ther; 1998 Jul; 286(1):136-41. PubMed ID: 9655852
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor affinity and analgesic activity of O- and C-glycosylated opioid peptides.
Negri L; Melchiorri P; Rocchi R; Scolaro B
Acta Physiol Hung; 1996; 84(4):441-3. PubMed ID: 9328626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
